A randomised double-blind controlled trial of BCNU as second-line therapy in metastatic oesophago-gastric, colorectal and pancreatic cancer

ABSTRACT: No description or hypothesis / outcomes information provided at time of study registration

DISEASE(S): Stomach Cancers,Oesophagus,Rectum,Colon,Pancreas

PROVIDER: 2420309 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR